Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma
- 11 November 2020
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 56 (4), 978-979
- https://doi.org/10.1038/s41409-020-01131-7
Abstract
No abstract availableKeywords
Funding Information
- Division of Cancer Prevention, National Cancer Institute (5P50 CA186781-04)
This publication has 7 references indexed in Scilit:
- The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple MyelomaTransplantation and Cellular Therapy, 2018
- Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftPublished by Wiley ,2018
- Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after TransplantationTransplantation and Cellular Therapy, 2016
- Efficient long-term cryopreservation of pluripotent stem cells at −80 °CScientific Reports, 2016
- When to recommend a second autograft in patients with relapsed myeloma?Leukemia & Lymphoma, 2016
- CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantationExperimental Hematology, 2001
- Effects of Long-Term Storage at -90°C of Bone Marrow and PBPC on Cell Recovery, Viability, and Clonogenic PotentialJournal of Hematotherapy, 1998